A combination of extracellular matrix (ECM) and supplements can obtain highly useful plateable human primary hepatocytes from inexpensive suspension-type
Improved S-TuD (Synthetic Tough Decoy) RNA nucleic acid that inhibits miR-200 family, which is highly expressed in mammary cancer, colon cancer, endometrial cancer, ovarian cancer, etc.
Focus on immune evasion mechanisms and cancer metabolism
Fusion protein X, which combines a RAS-binding domain, a cell membrane-permeable peptide, and a third domain, inhibits the function of activated RAS and degrades it.
New concept to deplete the cellular nucleic acid pool against transient nucleic acid demand during viral replication
Orally available micelle-type branched-chain amino acid prodrug
Polymeric nanoparticles with high specificity compared to an existing drug
Dichloroacetate nanoparticle accumulates in cancer tissue by EPR effect.